Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis.
Pratesi S, Nencini F, Grosso F, Dies L, Bormioli S, Cammelli D, Maggi E, Matucci A, Vultaggio A; ABIRISK Consortium. Pratesi S, et al. Among authors: cammelli d. Front Immunol. 2019 Jan 11;9:3113. doi: 10.3389/fimmu.2018.03113. eCollection 2018. Front Immunol. 2019. PMID: 30687319 Free PMC article.
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions.
Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Milla M, Prignano F, Annese V, Romagnani S, Maggi E, Matucci A; ABIRISK Consortium. Vultaggio A, et al. Among authors: cammelli d. Clin Exp Immunol. 2016 Dec;186(3):364-372. doi: 10.1111/cei.12858. Epub 2016 Oct 26. Clin Exp Immunol. 2016. PMID: 27569750 Free PMC article.
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders.
Nencini F, Vultaggio A, Pratesi S, Cammelli D, Milla M, Fiori G, Bagnoli S, Prignano F, Romagnani S, Maggi E, Matucci A. Nencini F, et al. Among authors: cammelli d. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2065-2072.e2. doi: 10.1016/j.jaip.2018.04.007. Epub 2018 Apr 13. J Allergy Clin Immunol Pract. 2018. PMID: 29660428
How the immune system responds to therapeutic biological agents.
Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Ferraro A, Maggi E, Matucci A. Vultaggio A, et al. Among authors: cammelli d. J Int Med Res. 2016 Sep;44(1 suppl):38-42. doi: 10.1177/0300060515593248. J Int Med Res. 2016. PMID: 27683137 Free PMC article.
Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
Vitiello G, Orsi Battaglini C, Carli G, Radice A, Matucci A, Vultaggio A, Olianti C, Parronchi P, Maggi E, Cammelli D. Vitiello G, et al. Among authors: cammelli d. Angiology. 2018 Oct;69(9):763-769. doi: 10.1177/0003319717753223. Epub 2018 Jan 17. Angiology. 2018. PMID: 29343075
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.
Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L. Sota J, et al. Among authors: cammelli d. Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019. Front Pharmacol. 2019. PMID: 31507416 Free PMC article.
A case of rheumatoid vasculitis.
Cammelli D, Vitiello G. Cammelli D, et al. Rheumatology (Oxford). 2016 Jun;55(6):1126. doi: 10.1093/rheumatology/kew149. Epub 2016 Apr 1. Rheumatology (Oxford). 2016. PMID: 27037329 No abstract available.
54 results